
Biosimilars Help Alvotech Revenues Soar Over 400% Year Over Year
Thanks to its successful biosimilar portfolio, Alvotech revenues jumped 427% in 2024 compared with 2023, showing immense growth year over year and proving that biosimilars are a profitable avenue for biopharmaceutical companies.1 Alvotech is an Iceland- …